Functional Repair of CFTR by CRISPR/Cas9 in Intestinal Stem Cell Organoids of Cystic Fibrosis Patients

Cited by (1,001)

Items 301–400 of 1,001

1. In Vivo Genome Editing Partially Restores Alpha1-Antitrypsin in a Murine Model of AAT Deficiency
   Chun‐Qing Song, Dan Wang, Tingting Jiang, Kevin W. O’Connor, Qiushi Tang, Lingling Cai, Xiangrui Li, Zhiping Weng, Hao Yin, Guangping Gao et al. · 2018 · Human Gene Therapy
2. CRISPR/Cas9-mediated somatic and germline gene correction to restore hemostasis in hemophilia B mice
   Cong Huai, Chenqiang Jia, Ruilin Sun, Peipei Xu, Taishan Min, Qihan Wang, Chengde Zheng, Hongyan Chen, Daru Lu · 2017 · Human Genetics
3. Targeted replacement of full-length CFTR in human airway stem cells by CRISPR-Cas9 for pan-mutation correction in the endogenous locus
   Sriram Vaidyanathan, Ron Baik, Lü Chen, Dawn T. Bravo, Carlos Jose Suarez, Shayda M. Abazari, Ameen Abdulla Salahudeen, Amanda M. Dudek, Christopher A. Teran, Timothy Davis et al. · 2021 · Molecular Therapy
4. Ethical Issues in Genome Editing using Crispr/Cas9 System
   Eduardo Rodrı́guez · 2016 · Journal of Clinical Research & Bioethics
5. Spermatogonial stem cell autotransplantation and germline genomic editing: a future cure for spermatogenic failure and prevention of transmission of genomic diseases
   Callista L. Mulder, Yi Zheng, Sabrina Z. Jan, Robin B. Struijk, Sjoerd Repping, Geert Hamer, Ans M. M. van Pelt · 2016 · Human Reproduction Update
6. Live cell imaging of mouse intestinal organoids reveals heterogeneity in their oxygenation
   Irina A. Okkelman, Tara Foley, Dmitri B. Papkovsky, Ruslan I. Dmitriev · 2017 · Biomaterials
7. Principles of and strategies for germline gene therapy
   Don P. Wolf, Paul A. Mitalipov, Shoukhrat M. Mitalipov · 2019 · Nature Medicine
8. Liver organoids reproduce alpha-1 antitrypsin deficiency-related liver disease
   Gema Gómez‐Mariano, Nerea Matamala, Selene Martínez, Iago Justo, Alberto Marcacuzco, C. Jiménez, Sara Monzón, Isabel Cuesta, Cristina Garfia, María Teresa Martínez et al. · 2019 · Hepatology International
9. Metabolic engineering to enhance the value of plants as green factories
   Ling Yuan, Erich Grotewold A · 2014 · Metabolic Engineering
10. Silica-based nanoparticles for therapeutic protein delivery
    Meihua Yu, Zhengying Gu, Thomas Ottewell, Chengzhong Yu · 2017 · Journal of Materials Chemistry B
11. Organoid technology in cancer precision medicine
    Xinyi Xia, Fei Li, Juan He, Rebiguli Aji, Dong Gao · 2019 · Cancer Letters
12. 3D Cell Culture—Can It Be As Popular as 2D Cell Culture?
    Miao Sun, An Liu, Xiao-Fu Yang, Jia-Xing Gong, Meng-Fei Yu, Xinhua Yao, Huiming Wang, Yong He · 2021 · Advanced NanoBiomed Research
13. RNA Therapeutics - Research and Clinical Advancements
    Rundong Feng, Suryaji Patil, Xin Zhao, Zhiping Miao, Airong Qian · 2021 · Frontiers in Molecular Biosciences
14. Cystic fibrosis: Toward personalized therapies
    Pauline T. Ikpa, Marcel J. C. Bijvelds, Hugo R. de Jonge · 2014 · The International Journal of Biochemistry & Cell Biology
15. Intestinal Organoids
    Thomas E. Wallach, James R. Bayrer · 2016 · Journal of Pediatric Gastroenterology and Nutrition
16. Towards manufacturing of human organoids
    Aswathi Ashok, Deepak Choudhury, Yu Fang, Walter Hunziker · 2019 · Biotechnology Advances
17. Personalized or Precision Medicine? The Example of Cystic Fibrosis
    Fernando Augusto Lima Marson · 2017 · Frontiers in Pharmacology
18. From Spheroids to Organoids: The Next Generation of Model Systems of Human Cardiac Regeneration in a Dish
    Mariangela Scalise, Fabiola Marino, Luca Salerno, Eleonora Cianflone, Claudia Molinaro, Nadia Salerno, Antonella De Angelis, Giuseppe Viglietto, Konrad Urbanek, Daniele Torella · 2021 · International Journal of Molecular Sciences
19. Intestinal enteroids/organoids: A novel platform for drug discovery in inflammatory bowel diseases
    Jun Hwan Yoo, Mark Donowitz · 2019 · World Journal of Gastroenterology
20. Strategies for genetic manipulation of adult stem cell-derived organoids
    Constantin Menche, Henner F. Farin · 2021 · Experimental & Molecular Medicine
21. Gastrointestinal organoids: How they gut it out
    Sebastian R. Merker, Jürgen Weitz, Daniel E. Stange · 2016 · Developmental Biology
22. Recommended guidelines for developing, qualifying, and implementing complex in vitro models (CIVMs) for drug discovery
    Ekert, Jason E., Deakyne, Julianna, Pribul-Allen, Philippa, Terry, Rebecca, Schofield, Christopher, Jeong, Claire G., Storey, Joanne, Mohamet, Lisa, Francis, Jo, Naidoo, Anita et al. · 2020 · SLAS DISCOVERY
23. The impact of CRISPR–Cas9 on target identification and validation
    Jonathan D. Moore · 2015 · Drug Discovery Today
24. Nanotechnology based CRISPR/Cas9 system delivery for genome editing: Progress and prospect
    Huan Deng, Wei Huang, Zhiping Zhang · 2019 · Nano Research
25. Organoid Technology: Current Standing and Future Perspectives
    Laleh Shariati, Yasaman Esmaeili, Shaghayegh Haghjooy Javanmard, Elham Bidram, Abbas Amini · 2021 · Stem Cells
26. Recent advances in CRISPR-Cas9-based genome insertion technologies
    Xinwen Chen, Jingjing Du, Shaowei Yun, Chaoyou Xue, Yao Yao, Shuquan Rao · 2024 · Molecular Therapy — Nucleic Acids
27. Prime editing functionally corrects cystic fibrosis-causing CFTR mutations in human organoids and airway epithelial cells
    Bulcaen, Mattijs, Kortleven, Phéline, Liu, Ronald B., Maule, Giulia, Dreano, Elise, Kelly, Mairead, Ensinck, Marjolein M., Thierie, Sam, Smits, Maxime, Ciciani, Matteo et al. · 2024 · Cell Reports Medicine
28. A Broad Overview and Review of CRISPR-Cas Technology and Stem Cells
    Simon N. Waddington, Riccardo Privolizzi, Rajvinder Karda, Helen C. O’Neill · 2016 · Current Stem Cell Reports
29. Treating Cystic Fibrosis with mRNA and CRISPR
    Alejandro Da Silva Sanchez, Kalina Paunovska, Ana Cristian, James E. Dahlman · 2020 · Human Gene Therapy
30. Ex Vivo COL7A1 Correction for Recessive Dystrophic Epidermolysis Bullosa Using CRISPR/Cas9 and Homology-Directed Repair
    Izmiryan, Araksya, Ganier, Clarisse, Bovolenta, Matteo, Schmitt, Alain, Mavilio, Fulvio, Hovnanian, Alain · 2018 · Molecular Therapy Nucleic Acids
31. Bioelectric stimulation controls tissue shape and size
    Gawoon Shim, Isaac B. Breinyn, Alejandro Martínez-Calvo, Sameeksha Rao, Daniel J. Cohen · 2024 · Nature Communications
32. Random Splicing of Several Exons Caused by a Single Base Change in the Target Exon of CRISPR/Cas9 Mediated Gene Knockout
    Marcel Kapahnke, Antje Banning, Ritva Tikkanen · 2016 · Cells
33. From Entry to Early Dissemination—Toxoplasma gondii's Initial Encounter With Its Host
    Estefania Delgado Betancourt, Benjamin Hamid, Benedikt T. Fabian, Christian Klotz, Susanne Hartmann, Frank Seeber · 2019 · Frontiers in Cellular and Infection Microbiology
34. Epithelial stem cells and intestinal cancer
    Shawna Tan, Nick Barker · 2014 · Seminars in Cancer Biology
35. Drug Discovery via Human-Derived Stem Cell Organoids
    Fangkun Liu, Jing Huang, Bo Ning, Zhixiong Liu, Shen Chen, Wei Zhao · 2016 · Frontiers in Pharmacology
36. Human Nasal Epithelial Organoids for Therapeutic Development in Cystic Fibrosis
    Zhongyu Liu, Justin D. Anderson, Lily Deng, Stephen Mackay, Johnathan Bailey, Latona Kersh, Steven Mark Rowe, Jennifer Susan Guimbellot · 2020 · Genes
37. Organoids and Colorectal Cancer
    Antonio Barbáchano, Asunción Fernández‐Barral, Pilar Bustamante‐Madrid, I. Prieto, Nuria Rodrı́guez-Salas, María Jesús Larriba, Alberto Múñoz · 2021 · Cancers
38. Human Lung Organoids—A Novel Experimental and Precision Medicine Approach
    Laura Kühl, Pauline Graichen, Nele von Daacke, Anne Mende, Małgorzata Wygrecka, Daniel P. Potaczek, Sarah Miethe, Holger Garn · 2023 · Cells
39. Organoid development in cancer genome discovery
    Dong Gao, Yu Chen · 2015 · Current Opinion in Genetics & Development
40. Organoid technologies meet genome engineering
    Jing Nie, Eri Hashino · 2017 · EMBO Reports
41. Targeted Gene Editing of Glia Maturation Factor in Microglia: a Novel Alzheimer’s Disease Therapeutic Target
    Sudhanshu P. Raikwar, Ramasamy Thangavel, Iuliia Dubova, Govindhasamy Pushpavathi Selvakumar, Mohammad Ejaz Ahmed, Duraisamy Kempuraj, Smita A. Zaheer, Shankar S. Iyer, Asgar Zaheer · 2018 · Molecular Neurobiology
42. New approaches to genetic therapies for cystic fibrosis
    A. Christopher Boyd, Shuling Guo, Lulu Huang, Batsheva Kerem, Yifat S. Oren, Amy J. Walker, Stephen L. Hart · 2020 · Journal of Cystic Fibrosis
43. Genetic engineering in organoids
    Teriyapirom, Isaree, Batista-Rocha, Andreia S., Koo, Bon-Kyoung · 2021 · Journal of Molecular Medicine
44. Organoids from adult liver and pancreas: Stem cell biology and biomedical utility
    Christopher J. Hindley, Lucía Cordero-Espinoza, Meritxell Huch · 2016 · Developmental Biology
45. Optimization of lipid-assisted nanoparticle for disturbing neutrophils-related inflammation
    Yang Liu, Zhiting Cao, Cong‐Fei Xu, Zi-Dong Lu, Ying‐Li Luo, Jun Wang · 2018 · Biomaterials
46. Bacterial CRISPR/Cas DNA endonucleases: A revolutionary technology that could dramatically impact viral research and treatment
    Edward M. Kennedy, Bryan R. Cullen · 2015 · Virology
47. Long-term culture and cloning of primary human bronchial basal cells that maintain multipotent differentiation capacity and CFTR channel function
    Jennifer R. Peters‐Hall, Melissa L. Coquelin, Michael J. Torres, Ryan LaRanger, Busola Ruth Alabi, Sei Sho, Josè F. Calva-Moreno, Philip Thomas, Jerry W. Shay · 2018 · American Journal of Physiology-Lung Cellular and Molecular Physiology
48. Organoids/organs-on-a-chip: new frontiers of intestinal pathophysiological models
    Lei Wu, Yongjian Ai, Ruoxiao Xie, Jialiang Xiong, Yu Wang, Qionglin Liang · 2023 · Lab on a Chip
49. Application of CRISPR/Cas9 genome editing to the study and treatment of disease
    Andrea Pellagatti, Hamid Dolatshad, Simona Valletta, Jacqueline Boultwood · 2015 · Archives of Toxicology
50. Targeted therapies to improve CFTR function in cystic fibrosis
    Malcolm Brodlie, Iram Haq, Katie Roberts, J.S. Elborn · 2015 · Genome Medicine
51. Generation of CRISPR–Cas9-mediated genetic knockout human intestinal tissue–derived enteroid lines by lentivirus transduction and single-cell cloning
    Lin, Shih-Ching, Haga, Kei, Zeng, Xi-Lei, Estes, Mary K. · 2022 · Nature Protocols
52. Tailored Pig Models for Preclinical Efficacy and Safety Testing of Targeted Therapies
    Nikolai Klymiuk, Frank Seeliger, Mohammad Bohlooly‐Y, Andreas Blutke, Daniel G. Rudmann, Eckhard Wolf · 2015 · Toxicologic Pathology
53. Dawn of the organoid era
    Ninouk Akkerman, Libert H.K. Defize · 2017 · BioEssays
54. Therapeutic Editing of the TP53 Gene: Is CRISPR/Cas9 an Option?
    Regina Mirgayazova, Raniya Khadiullina, Vitaly V. Chasov, Rimma N. Mingaleeva, Мифтахова Регина Рифкатовна, Albert Anatolyevich Rizvanov, Emil Bulatov · 2020 · Genes
55. Spatial and Temporal Control of CRISPR-Cas9-Mediated Gene Editing Delivered via a Light-Triggered Liposome System
    Yagiz Alp Aksoy, Biyao Yang, Wenjie Chen, Tzong‐Tyng Hung, Rhiannon P. Kuchel, Nathan W. Zammit, Shane T. Grey, Ewa Magdalena Goldys, Wei Deng · 2020 · ACS Applied Materials & Interfaces
56. CRISPR/Cas9-Mediated In Situ Correction of LAMB3 Gene in Keratinocytes Derived from a Junctional Epidermolysis Bullosa Patient
    Daniela Benati, Francesca Miselli, Fabienne Cocchiarella, Clarissa Patrizi, Marta Carretero, Samantha Baldassarri, Virginia Ammendola, Cristina Has, Stefano Colloca, Marcela Del Río et al. · 2018 · Molecular Therapy
57. Brain Organoids as Tools for Modeling Human Neurodevelopmental Disorders
    Jason W. Adams, Fernanda R. Cugola, Alysson Renato Muotri · 2019 · Physiology
58. Customizing the genome as therapy for the β-hemoglobinopathies.
    Canver, Matthew C., Orkin, Stuart H. · 2016 · Blood
59. Therapeutic Approaches for Patients with Cystic Fibrosis Not Eligible for Current CFTR Modulators
    Isabelle Fajac, Isabelle Sermet‐Gaudelus · 2021 · Cells
60. Breaking the mold: 3D cell cultures reshaping the future of cancer research
    Sandra Zorat Cordeiro, Beatriz B P P Oliveira, Rúben Valente, Daniela Ferreira, André Luz, Pedro Viana Baptista, Alexandra Ramos Fernandes · 2024 · Frontiers in Cell and Developmental Biology
61. Dual Supramolecular Nanoparticle Vectors Enable CRISPR/Cas9‐Mediated Knockin of Retinoschisin 1 Gene—A Potential Nonviral Therapeutic Solution for X‐Linked Juvenile Retinoschisis
    Shih‐Jie Chou, Peng Yang, Qian Ban, Yi Ping Yang, Mong‐Lien Wang, Chian‐Shiu Chien, Shih Jen Chen, Na Sun, Yazhen Zhu, Hongtao Liu et al. · 2020 · Advanced Science
62. New horizons for cystic fibrosis treatment
    Isabelle Fajac, K. De Boeck · 2016 · Pharmacology & Therapeutics
63. Strategies for the etiological therapy of cystic fibrosis
    Luigi Maiuri, Valeria Raia, Guido Kroemer · 2017 · Cell Death and Differentiation
64. Functional correction of CFTR mutations in human airway epithelial cells using adenine base editors
    Sateesh Krishnamurthy, Soumba Traore, Ashley L. Cooney, Christian M. Brommel, Katarina Kulhánková, Patrick L. Sinn, Gregory A. Newby, David R. Liu, Paul B. McCray · 2021 · Nucleic Acids Research
65. Primary human organoids models: Current progress and key milestones
    Giuseppe Calà, Beatrice Sina, Paolo De Coppi, Giovanni Giuseppe Giobbe, M Gerli · 2023 · Frontiers in Bioengineering and Biotechnology
66. Advancements in pathology: Digital transformation, precision medicine, and beyond
    Sana Ahuja, Sufian Zaheer · 2024 · Journal of Pathology Informatics
67. Translating the genetics of cystic fibrosis to personalized medicine
    Harriet Corvol, Kristin E. Thompson, Olivier Tabary, Philippe Le Rouzic, Loïc Guillot · 2015 · Translational research
68. Beyond editing to writing large genomes
    Raj Chari, George McDonald Church · 2017 · Nature Reviews Genetics
69. Delivery Approaches for Therapeutic Genome Editing and Challenges
    Ilayda Ates, Tanner Rathbone, Callie Stuart, P. Hudson Bridges, Renee N. Cottle · 2020 · Genes
70. New treatments targeting the basic defects in cystic fibrosis
    Isabelle Fajac, Claire Elizabeth Wainwright · 2017 · La Presse Médicale
71. Genome Editing by CRISPR /Cas9: A Game Change in the Genetic Manipulation of Protists
    Noelia Marina Lander, Miguel Ángel Chiurillo, Roberto Docampo · 2016 · Journal of Eukaryotic Microbiology
72. Cellular self-assembly and biomaterials-based organoid models of development and diseases
    Shivem B. Shah, Ankur K. Singh · 2017 · Acta Biomaterialia
73. Era of Genomic Medicine: A Narrative Review on CRISPR Technology as a Potential Therapeutic Tool for Human Diseases
    O. W. Kotagama, Chanika Dilumi Jayasinghe, Thelma Abeysinghe · 2019 · BioMed Research International
74. Lipid- and polymer-based nanoparticle systems for the delivery of CRISPR/Cas9
    Bhaargavi Ashok, Nicholas A. Peppas, Marissa E. Wechsler · 2021 · Journal of Drug Delivery Science and Technology
75. Nanoparticles-mediated CRISPR-Cas9 gene therapy in inherited retinal diseases: applications, challenges, and emerging opportunities
    Yueh Chien, Yu‐Jer Hsiao, Shih‐Jie Chou, Ting-Yi Lin, Aliaksandr A. Yarmishyn, Weiyi Lai, Meng‐Shiue Lee, Yi‐Ying Lin, Tzu-Wei Lin, De‐Kuang Hwang et al. · 2022 · Journal of Nanobiotechnology
76. CRISPR-Cas9: a promising tool for gene editing on induced pluripotent stem cells
    Eun Ji Kim, Ki Ho Kang, Ji Hyeon Ju · 2017 · The Korean Journal of Internal Medicine
77. Automated Cell Culture Systems and Their Applications to Human Pluripotent Stem Cell Studies
    Maciej Daniszewski, Duncan E. Crombie, Rachael Henderson, Helena Hai Liang, Raymond C.B. Wong, Alex William Hewitt, Alice Pébay · 2017 · SLAS TECHNOLOGY
78. Recent advances in developing therapeutics for cystic fibrosis
    Lisa J. Strug, Anne L. Stephenson, Naim Panjwani, Ann Harris · 2018 · Human Molecular Genetics
79. Innovative Therapeutic Strategies for Cystic Fibrosis: Moving Forward to CRISPR Technique
    Michele Marangi, Giuseppa Pistritto · 2018 · Frontiers in Pharmacology
80. Gold Nanoparticle-Mediated Gene Therapy
    Gayathri A. Kanu, Javad B. M. Parambath, Raed O. Abu Odeh, Ahmed A. M. Mohamed · 2022 · Cancers
81. Gastric Organoids: An Emerging Model System to Study Helicobacter pylori Pathogenesis
    Malvika Pompaiah, Sina Bartfeld · 2017 · Current topics in microbiology and immunology
82. Intestinal Stem Cells to Advance Drug Development, Precision, and Regenerative Medicine: A Paradigm Shift in Translational Research
    Jonathan Paul Mochel, Albert E. Jergens, Dawn D. Kingsbury, Hyun Jung Kim, Martı́n G. Martı́n, Karin Allenspach · 2017 · The AAPS Journal
83. Modeling Wnt signaling by CRISPR-Cas9 genome editing recapitulates neoplasia in human Barrett epithelial organoids
    Xi Liu, Yulan Cheng, John M. Abraham, Zhixiong Wang, Zhe Wang, Xiquan Ke, Rong Yan, Eun Ji Shin, Saowanee Ngamruengphong, Mouen A. Khashab et al. · 2018 · Cancer Letters
84. Kidney organoids in translational medicine: Disease modeling and regenerative medicine
    Tomoya Miyoshi, Ken Hiratsuka, Edgar Garcia Saiz, Ryuji Morizane · 2019 · Developmental Dynamics
85. Utilizing Organoid and Air-Liquid Interface Models as a Screening Method in the Development of New Host Defense Peptides
    Ka-Yee Grace Choi, Bing Catherine Wu, Amy Huei‐Yi Lee, Beverlie Baquir, Robert E. W. Hancock · 2020 · Frontiers in Cellular and Infection Microbiology
86. Screening Cancer Immunotherapy: When Engineering Approaches Meet Artificial Intelligence
    Xingwu Zhou, Moyuan Qu, Peyton J. Tebon, Xing Jiang, Canran Wang, Yumeng Xue, Jixiang Zhu, Shiming Zhang, Rahmi Öklü, Shiladitya Sengupta et al. · 2020 · Advanced Science
87. Antiestrogen Resistant Cell Lines Expressing Estrogen Receptor α Mutations Upregulate the Unfolded Protein Response and are Killed by BHPI
    Chengjian Mao, Mara R. Livezey, Ji Eun Kim, David J. Shapiro · 2016 · Scientific Reports
88. Delivery of genome-editing biomacromolecules for treatment of lung genetic disorders
    Tao Yu Wan, Ping Yuan · 2020 · Advanced Drug Delivery Reviews
89. Cas9-Based Genome Editing in Zebrafish
    Andrew P. W. Gonzales, Jing-Ruey Joanna Yeh · 2014 · Methods in enzymology on CD-ROM/Methods in enzymology
90. Genetic medicines for CF: Hype versus reality
    Alton, Eric W.F.W., Boyd, A. Christopher, Davies, Jane C., Gill, Deborah R., Griesenbach, Uta, Harrison, Patrick T., Henig, Noreen, Higgins, Tracy, Hyde, Stephen C., Innes, J. Alastair et al. · 2016 · Pediatric Pulmonology
91. Efficient Homology-Directed Repair with Circular Single-Stranded DNA Donors
    Sukanya Iyer, Aamir Mir, Joel Vega‐Badillo, Benjamin P. Roscoe, Raed Ibraheim, Lihua Julie Zhu, Jooyoung Lee, Pengpeng Liu, Kevin Luk, Esther Mintzer et al. · 2022 · The CRISPR Journal
92. Targeted Integration of a Super-Exon into the CFTR Locus Leads to Functional Correction of a Cystic Fibrosis Cell Line Model
    Christien Bednarski, Katja Tomczak, Beate vom Hövel, Wolf-Michael Weber, Toni Cathomen · 2016 · PLoS ONE
93. Survival and Evolution of CRISPR–Cas System in Prokaryotes and Its Applications
    Muhammad Abu Bakr Shabbir, Haihong Hao, Muhammad Zubair Shabbir, Hafiz Iftikhar Hussain, Iqbal Zahid, Saeed Ahmed, Adeel Sattar, Mujahid Iqbal, Jun Li, Zonghui Yuan · 2016 · Frontiers in Immunology
94. How to create state-of-the-art genetic model systems: strategies for optimal CRISPR-mediated genome editing
    Yannik Bollen, Jasmin B. Post, Bon‐Kyoung Koo, Hugo J.G. Snippert · 2018 · Nucleic Acids Research
95. Strategies against Nonsense: Oxadiazoles as Translational Readthrough-Inducing Drugs (TRIDs)
    Ambra Campofelice, Laura Lentini, Aldo Di Leonardo, Raffaella Melfi, Marco Tutone, Andrea Pace, Ivana Pibiri · 2019 · International Journal of Molecular Sciences
96. Human pluripotent stem cell‐derived lung organoids: Potential applications in development and disease modeling
    Lu Tian, Jinghui Gao, Irving M. Garcia, Huanhuan Joyce Chen, Alessandra Castaldi, Ya‐Wen Chen · 2020 · Wiley Interdisciplinary Reviews Developmental Biology
97. CRISPR technology: The engine that drives cancer therapy
    Mingtao Zhang, Emily A. Eshraghian, Omar Al Jammal, Zhi-Bi Zhang, Xiao Ming Zhu · 2020 · Biomedicine & Pharmacotherapy
98. Heritable human genome editing: Research progress, ethical considerations, and hurdles to clinical practice
    Jenna M. Turocy, Eli Y. Adashi, Dieter M. Egli · 2021 · Cell
99. Pluripotent Stem Cell Platforms for Drug Discovery
    Kevin G. Chen, Barbara S. Mallon, Kyeyoon Park, Pamela Gehron Robey, Ronald D.G. McKay, Michael M. Gottesman, Wei Zheng · 2018 · Trends in Molecular Medicine
100. Anaerobiosis influences virulence properties of Pseudomonas aeruginosa cystic fibrosis isolates and the interaction with Staphylococcus aureus
     Ross Pallett, Laura Jane Leslie, Peter A. Lambert, Ivana Milic, Andrew Devitt, Lindsay J. Marshall · 2019 · Scientific Reports